Literature DB >> 8294310

Understanding thrombin and hemostasis.

J W Fenton1, F A Ofosu, D V Brezniak, H I Hassouna.   

Abstract

Unlike other factors in blood coagulation and fibrinolysis, thrombin has several functions in hemostasis from injury to recovery. Because of continual consumption, thrombin generation controls prethrombotic thrombin functions and may be prevented by inactivation of its precursors or by inhibition of thrombin-mediated amplification steps. The direct activation product of prothrombin, alpha-thrombin, not only converts fibrinogen into clottable fibrin but also is actively incorporated into the forming thrombus, where it is protected and transformed into other or inactive forms with thrombus maturation. Larger protein inhibitors, such as antithrombin III, cannot penetrate the thrombus, whereas hirudin and small thrombin inhibitors can. Unique structural features of thrombin allow the design and synthesis of a variety of small inhibitors. Such small inhibitors may prevent rethrombosis upon lysis of immature thrombi. On the other hand, such intervention must be used with caution, because low levels of thrombin appear to promote wound healing. In this regard, the scars of healing are but manifestations of the many functions of thrombin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8294310

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  7 in total

1.  Heterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery.

Authors:  J R Hamilton; T M Cocks
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Heparin enhances the catalytic activity of des-ETW-thrombin.

Authors:  C A Goodwin; J J Deadman; B F Le Bonniec; S Elgendy; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

3.  Mice lacking the thrombin receptor, PAR1, have normal skin wound healing.

Authors:  A J Connolly; D Y Suh; T K Hunt; S R Coughlin
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

4.  Anticoagulant and antiplatelet activities of novel serine protease purified from seeds of Cucumis maderaspatensis.

Authors:  H R Sachin; M N SharathKumar; S Devaraja; A H Sneharani
Journal:  3 Biotech       Date:  2021-01-04       Impact factor: 2.406

5.  Two acidic, anticoagulant PLA2 isoenzymes purified from the venom of monocled cobra Naja kaouthia exhibit different potency to inhibit thrombin and factor Xa via phospholipids independent, non-enzymatic mechanism.

Authors:  Ashis K Mukherjee; Bhargab Kalita; Rupamoni Thakur
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

6.  Anticoagulant mechanism, pharmacological activity, and assessment of preclinical safety of a novel fibrin(ogen)olytic serine protease from leaves of Leucas indica.

Authors:  Debananda Gogoi; Neha Arora; Bhargab Kalita; Rahul Sarma; Taufikul Islam; Sidhhartha S Ghosh; Rajlakshmi Devi; Ashis K Mukherjee
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

7.  Thrombolytic Potential of Novel Thiol-Dependent Fibrinolytic Protease from Bacillus cereus RSA1.

Authors:  Chhavi Sharma; Gad Elsayed Mohamed Salem; Neha Sharma; Prerna Gautam; Rajni Singh
Journal:  Biomolecules       Date:  2019-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.